Dr. Federico Demarchi graduated from the University of Turin with a degree in Pharmacy and completed a Specialisation in Hospital Pharmacy at the same university. He further developed his professional profile by attending the Advanced Training Course in Health Technology Assessment (COPHTA) at LIUC Business School.
During his training, he completed internships and professional training at the A.O.U. Città della Salute e della Scienza di Torino. He was also awarded two University of Turin scholarships focusing on monitoring the use of monoclonal antibodies and on the HTA evaluation of medical devices in the oncology setting.
He has served as a speaker in courses and seminars on Health Technology Assessment and the management of venous access.
He is a member of SIFO’s Scientific and Cultural Area for Advanced Therapies, Biotechnology, Pharmacogenetics and Pharmacogenomics.
He is the author and co-author of scientific publications and contributions presented at national conferences.